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EFFECTS OF INTRAVENOUS ADMINISTRATION OF FAT
EMULSIONS AND THEIR EMULSIFYING AGENTS
II. EFFECTS OF PHOSPHATIDE PREPARATIONS ON THE COAGULATION
OF THE BLOOD OF D0GS*
PRELIMINARY REPORT
E. KLEIN, M.D., J. V. GARRETT, M.D. AND W. F. LEVER, M.D.
The observation that the intravenous administration of an aqueous suspelision
of soybean phosphatides to dogs results in the appearance of clearing factor
activity, as well as prolongation of the whole blood clotting time, has been re-
ported by Lever et al. (1) It was also shown that the subsequent intravenous
administration of protamine reversed these changes. A preliminary report of
the effects of intravenous phosphatide administration on the various phases of
coagulation is being presented here.
METHODS AND MATERIALS
Samples of blood were obtained as described in the preceding paper (1). Whole blood
clotting time was determined according to the method of Lee and White (2). Prothrombin
consumption was tested by the method of Alexander (3). Calcium clotting time was deter-
mined according to the method of Quick (4, 5). The thromboplastin generation test was
carried out by a modification (6) of the method of Biggs and Douglas (7). The thrombin time
was determined by a method described previously (8).
Lyophilized platelet material (LPM) was prepared as described previously (9). LPM
was added in vitro to the plasma obtained after phosphatide administration to reach the
equivalent of approximately 1,000,000 platelets per Cu. mm. LPM was used as a source of
antiheparin activity.
RESULTS
In 7 experiments it was found that the conversion of prothrombin to thrombin,
the conversion of fibrinogen to fibrin by thrombin and the rate of thromboplastin
generation were inhibited after the intravenous administration of phosphatides.
The maximum level of thromboplastin generation (as indicated by the clotting
line of the substrate), however, was normal, even when platelets were not added
to the incubation mixture. All inhibitory phenomena were reversed after the
intravenous administration of protamine.
When lyophilized platelet material was added to plasma in vitro, the inhibition
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TABLE I
The Effects of Intravenous Administration of a Soybean Phosphatide Preparation on the
Coagulation Mechanism of the Dog
Phosphatide After Protamine
-
Platelets Added in vitro
Whole blood clotting time...... elevated reversal to normal —
Calcium clotting time elevated reversal to normal reversal to normal
Prothrombin time elevated reversal to normal reversal to normal
Thrombin time elevated reversal to normal reversal to normal
Prothrombin consumption decreased reversal to normal —
Thromboplastin generation test
Minimum time to reach maximal
activity elevated* reversal to normal reversal to normal
Minimum clotting time of sub-
strate decreased unchanged, normal normal
to normal
C
* In absence of platelets
TABLE II
Representative Data on the Effects of Intravenous Administration of a Soybean Phosphatide
Preparation on the Coagulation Mechanism of the Dog
.Unit Before Phos-phatides
After
Phosphatides
After
Protamine
140
84
16
Plateletsj,
—
92
17
Whole blood clotting time
Calcium clotting time
Prothrombin time
sec.
sec.
sec.
80
62
14
1200
614
32
Thrombin time sec. 11 23 15 10
Prothrombin consumption
Thromboplastiri generation test
Minimum time to reach maximal
% 100% 50% 80% —
activity
Minimum clotting time of sub-
strate
mm.
sec.
4*
23*
27
11
5
11
6
12
* In absence of platelets
of the various phases of coagulation was also reversed. These findings are tabu-
lated below. (Table I)
Representative data are shown in Table Ii.
DISCUSSION
The appearance of a lipemia-clearing activity in the blood following the intra-
venous administration of soybean phosphatide suspension to dogs is accompanied
by an anticoagulant activity, which affects the three phases of the coagulation
mechanism which are inhibited by heparin (i.e., the conversion of prothrombin,
the conversion of fibrinogen and the decrease of t.he rate of thromboplastin
generation).
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The administration of protamine led to reversal of the phosphatide-induced
inhibition of coagulation. This indicates that the anticoagulant activity was
associated with a polyanionic moiety. The reversal of the inhibition by lyophi-
lized platelet material (9) and by a fraction of platelets (10) with which specific
antiheparin activity is associated, suggests furthermore, that the anticoagulant
activity is brought about by an heparinoid moiety. The antiheparin fraction of
platelets has been found to reverse the anticoagulant activities of sulfated
polysaceharides but not of polyanionic structures in general (11).
The thromboplastin generation test was carried out with saline added to the
incubation mixture in place of platelets. The fact that normal levels of thrombo-
plastin were generated even in the absence of platelets is explained by the ability
of the soybean phosphatide to replace platelets (12) in this test.
The apparent paradox of the administration of a potentially clot-promoting
agent leading to the appearance of anticogulant activity in the recipient's blood
can be explained by a secondary release of anticoagulant.* In evaluating these
results it should be noted that the soybean phosphatide preparation was not
purified and it is therefore possible that it contained impurities which by them-
selves act as anticoagulants. The effect of in vitro addition of this phosphatide
preparation to the respective coagulation test systems was therefore studied
concurrently (12) and it was found that even though anticoagulant components
are present in crude preparations of soybean phosphatides, the overall activity
of the preparation resulted in the generation of thromboplastin. It is possible,
however, that in vivo the clot-promoting components of the preparation dis-
appeared, while the anticoagulant fraction remained in the blood stream.
In preliminary studies with smaller amounts of phosphatide anticoagulation
was not encountered. Nevertheless, the appearance of anticoagulant activity
following phosphatide administration may be of importance should phosphatide
preparations be used for the correction of the coagulation defect associated with
thrombocytopenia. A deficiency of platelets makes the recipient more susceptible
to the induction of anticoagulant activities both for the reason of a pre-existing
hemostatic defect and because of the apparently specific activity by which plate-
lets can reverse that type of anticoagulant activity.
SUMMARY
Production of lipemia-clearing factor produced in the blood of dogs by the
intravenous administration of phosphatide preparations is associated with the
appearance of anticoagulant activity which resembles heparin in its effects on
the various phases of coagulation. Like heparin this post-phosphatide activity
is reversed by protamine in vivo and by platelet material in vitro.
*It should also be pointed out that high concentrations of phosphatide inhibit coagula-
tion, This does not seem to be applicable here, since inhibition does not occur until at least
ten times the amount of phosphatide optimal for maximum thromboplastin generation is
present. Furthermore, the inhibition induced by excess phosphatide is directed primarily
against the generation of thromboplastin (11), and only at very high concentrations against
the conversion of prothrombin to thrombin or the conversion of fibrinogen to fibrin by
thrombin (13).
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